Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1967 1
1970 3
1972 2
1973 3
1974 7
1975 4
1976 6
1977 8
1978 4
1979 8
1980 5
1981 1
1982 5
1983 3
1984 4
1985 6
1986 8
1987 5
1988 17
1989 17
1990 10
1991 18
1992 26
1993 21
1994 43
1995 71
1996 77
1997 57
1998 53
1999 81
2000 47
2001 78
2002 92
2003 81
2004 156
2005 133
2006 147
2007 143
2008 211
2009 189
2010 184
2011 221
2012 268
2013 264
2014 269
2015 204
2016 212
2017 277
2018 290
2019 302
2020 266
2021 150
2022 47
2023 76
2024 339
2025 346
2026 65

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial, Systematic Review, in the last 1 year. Clear all
Page 1
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials.
Danzig CJ, Dinah C, Ghanchi F, Hattenbach LO, Khanani AM, Lai TYY, Shimura M, Abreu F, Arrisi P, Liu Y, Paris LP, Retiere AC, Willis JR, Schlottmann PG; BALATON and COMINO Investigators. Danzig CJ, et al. Ophthalmol Retina. 2025 Sep;9(9):848-859. doi: 10.1016/j.oret.2025.03.005. Epub 2025 Mar 17. Ophthalmol Retina. 2025. PMID: 40107501 Free article. Clinical Trial.
Resolution of Angiographic Macular Leakage with Faricimab versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE.
Goldberg RA, Mar FA, Csaky K, Amador M, Khanani AM, Gibson K, Kolomeyer AM, Sim DA, Murata T, Wang T, Udaondo P, Souverain A, Shildkrot YE, Vujosevic S, Nudleman E, Sivaprasad S. Goldberg RA, et al. Ophthalmol Retina. 2025 Jun;9(6):515-526. doi: 10.1016/j.oret.2024.11.015. Epub 2024 Nov 22. Ophthalmol Retina. 2025. PMID: 39580145 Free article. Clinical Trial.
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE.
Wykoff CC, Holz FG, Chiang A, Boyer D, Dhoot DS, Loewenstein A, Mones J, Heier J, Abbey AM, Singerman LJ, Vajzovic L, Lin J, Li C, Vilupuru A, Baumal CR; OAKS, DERBY, and GALE Investigators. Wykoff CC, et al. Am J Ophthalmol. 2025 Aug;276:350-364. doi: 10.1016/j.ajo.2025.04.016. Epub 2025 Apr 23. Am J Ophthalmol. 2025. PMID: 40280279 Free article. Clinical Trial.
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.
Khanani AM, Campochiaro PA, Graff JM, Marcus DM, Miller D, Mittra RA, Regillo C, Sheth VS, Bobbala A, Gune S, Lin S, Quezada-Ruiz C, Malhotra V. Khanani AM, et al. JAMA Ophthalmol. 2025 Apr 1;143(4):326-335. doi: 10.1001/jamaophthalmol.2025.0006. JAMA Ophthalmol. 2025. PMID: 40048197 Free PMC article. Clinical Trial.
Neural mechanisms of psychedelic visual imagery.
Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. Stoliker D, et al. Mol Psychiatry. 2025 Apr;30(4):1259-1266. doi: 10.1038/s41380-024-02632-3. Epub 2024 Jun 11. Mol Psychiatry. 2025. PMID: 38862674 Free PMC article. Clinical Trial.
Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis.
Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E, Cehofski LJ, Ferro Desideri L, van Dijk EHC, Faber C, Grauslund J, Hajari JN, Huemer J, Klefter ON, Krogh Nielsen M, Sabaner MC, Schneider M, Subhi Y. Butler ETS, et al. Acta Ophthalmol. 2025 Nov;103(7):741-763. doi: 10.1111/aos.17506. Epub 2025 Apr 17. Acta Ophthalmol. 2025. PMID: 40241463 Free PMC article.
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial.
Korobelnik JF, Lanzetta P, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Sun X, Berliner AJ, Schulze A, Zhao M, Schmelter T, Schmidt-Ott U, Zhang X, Morgan-Warren P, Hasanbasic Z, Vitti R, Chu KW, Reed K, Bhore R, Cheng Y, Bai Z, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Korobelnik JF, et al. Ophthalmology. 2026 Jan;133(1):39-50. doi: 10.1016/j.ophtha.2025.08.022. Epub 2025 Aug 26. Ophthalmology. 2026. PMID: 40876598 Free article. Clinical Trial.
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.
Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P. Pieramici DJ, et al. JAMA Ophthalmol. 2025 Apr 1;143(4):317-325. doi: 10.1001/jamaophthalmol.2025.0001. JAMA Ophthalmol. 2025. PMID: 40048178 Free PMC article. Clinical Trial.
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.
Nysom K, Kilburn LB, Leary SES, Landi DB, de Vos-Kerkhof E, Perreault S, Witt O, Ziegler DS, Hernáiz Driever P, Franson AT, Baxter PA, Whipple NS, Kline C, Segal D, Jabado N, Bailey S, McCowage G, Hansford JR, Khuong-Quang DA, Gottardo NG, Hassall T, Han JW, Yalon Oren M, Chi SN, Qiu J, Da Costa D, Govinda Raju S, Manley P, Hargrave D. Nysom K, et al. Neuro Oncol. 2025 Jun 21;27(5):1341-1355. doi: 10.1093/neuonc/noae274. Neuro Oncol. 2025. PMID: 39700439 Free PMC article. Clinical Trial.
Visual Loss in Geographic Atrophy: Learnings from the Lampalizumab Trials.
Anegondi N, Steffen V, Sadda SR, Schmitz-Valckenberg S, Tufail A, Csaky K, Lad EM, Kaiser PK, Ferrara D, Chakravarthy U. Anegondi N, et al. Ophthalmology. 2025 Apr;132(4):420-430. doi: 10.1016/j.ophtha.2024.11.017. Epub 2024 Nov 23. Ophthalmology. 2025. PMID: 39581330 Free article. Clinical Trial.
Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review.
Nanji K, Hatamnejad A, Grad J, El-Sayes A, Mihalache A, Gemae M, Huang R, Phillips M, Zeraatkar D, Singh R, Munk MR, Sadda SR, Sarraf D, Kaiser P, Guymer R, Sivaprasad S, Fraser-Bell S, Tham YC, Garg SJ, Wong TY, Wykoff CC, Chaudhary V. Nanji K, et al. Surv Ophthalmol. 2026 Mar-Apr;71(2):289-308. doi: 10.1016/j.survophthal.2025.09.009. Epub 2025 Sep 17. Surv Ophthalmol. 2026. PMID: 40967513 Free article.
Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One-year results.
Alvarez-Peregrina C, Sanchez-Tena MA, Villa-Collar C, Martinez-Perez C, de Corcuera-Terrero B, Liu N, Li W, Sankaridurg P, Ohlendorf A; Clinical Evaluation of MyoCare in Europe – the CEME Study Group. Alvarez-Peregrina C, et al. Ophthalmic Physiol Opt. 2025 Jun;45(4):1025-1035. doi: 10.1111/opo.13517. Epub 2025 Apr 29. Ophthalmic Physiol Opt. 2025. PMID: 40296784 Free PMC article. Clinical Trial.
Treat-And-Extend Versus Pro Re Nata Regimen of Intravitreal Conbercept Injection for Neovascular Age-Related Macular Degeneration: Results from COCOA, a Prospective, Open-Label, Multicenter, Randomized Phase IV Clinical Trial.
Sun Y, Zhang W, Hu B, Sun B, Zhang T, Yu S, Yuan G, Dai R, Fan K, Wang L, Cheng P, An G, An L, Wang F, Chen W, Zhang J, Zhou X, Wang F, Ye J, Huang X, Peng X, Li J, Wu M, Wan G, Zhong J, Ha S, Ke X, Liang J, Qi H, Yin H, Qian T, Qu J, Shi X, Hou J, Miao H, Yao Y, Jin E, Deng X, Zhang J, Shi X, Liu J, Ma J, Liu J, Tao Y, Liu B, Li X, Zhao M. Sun Y, et al. Semin Ophthalmol. 2025 Jul;40(5):393-399. doi: 10.1080/08820538.2025.2467853. Epub 2025 Mar 13. Semin Ophthalmol. 2025. PMID: 40079155 Clinical Trial.
Clinical features of retinal vasculitis: A systematic review and meta-analysis from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3.
Cifuentes-González C, Le Tong Y, Rojas-Carabali W, Mejía-Salgado G, Putera I, Song XYR, Walter CFY, Shengjuan Z, Chan R, Mobasserian A, Nora RD, Biswas J, Gangaputra S, Pulido JS, Kempen JH, Nguyen QD, de la Torre A, Gupta V, Rosenbaum JT, Agrawal R; REVISE-IUSG study group. Cifuentes-González C, et al. Surv Ophthalmol. 2025 Nov-Dec;70(6):1144-1159. doi: 10.1016/j.survophthal.2025.04.001. Epub 2025 May 2. Surv Ophthalmol. 2025. PMID: 40320076
Baseline OCT Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-analysis.
Nanji K, Grad J, Hatamnejad A, El-Sayes A, Mihalache A, Gemae M, Huang R, Phillips M, Kaiser PK, Munk MR, Garg SJ, Sarraf D, Sadda SR, Fraser-Bell S, Zeraatkar D, Ma J, Borrelli E, Steel DH, Sivaprasad S, Wykoff CC, Chaudhary V. Nanji K, et al. Ophthalmology. 2026 Jan;133(1):75-90. doi: 10.1016/j.ophtha.2025.07.038. Epub 2025 Aug 11. Ophthalmology. 2026. PMID: 40803536 Free article.
Effects of Prenatal DHA Dose on Infant Visual Attention.
Colombo J, Shaddy DJ, Mathis N, Christifano DN, Brown AR, Gajewski BJ, Carlson SE, Gustafson KM. Colombo J, et al. Dev Psychobiol. 2025 Sep;67(5):e70072. doi: 10.1002/dev.70072. Dev Psychobiol. 2025. PMID: 40791013 Clinical Trial.
Predicting treatment response in retinal vein occlusions using baseline optical coherence tomography biomarkers: A systematic review.
Hatamnejad A, Nanji K, Grad J, El-Sayes A, Mihalache A, Gemae M, Huang R, Waheed NK, Sarraf D, Sadda SR, Wong TY, Zeraatkar D, Ma J, Garg SJ, Munk MR, Borrelli E, Steel DH, Sivaprasad S, Wykoff CC, Chaudhary V. Hatamnejad A, et al. Surv Ophthalmol. 2026 Jan-Feb;71(1):100-118. doi: 10.1016/j.survophthal.2025.08.016. Epub 2025 Sep 4. Surv Ophthalmol. 2026. PMID: 40914443 Free article.
A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning.
Gutfleisch M, Heimes-Bussmann B, Aydin S, Petrovic R, Loktyushin A, Ohji M, Takahashi K, Okada AA, Scholz P, Youssef H, Bauer-Steinhusen U, Machewitz T, Rothaus K, Lommatzsch A. Gutfleisch M, et al. Graefes Arch Clin Exp Ophthalmol. 2025 Jul;263(7):1885-1897. doi: 10.1007/s00417-025-06812-x. Epub 2025 Apr 10. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40210713 Free PMC article. Clinical Trial.
Ab-Externo MicroShunt vs. Trabeculectomy in Primary Open-Angle Glaucoma: 5-Year Safety Results from a Randomized, Multicenter Study.
Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Stiles MC, Brandt JD, Beckers HJM, Strouthidis NG; INN005 Study Group. Panarelli JF, et al. Ophthalmol Glaucoma. 2026 Jan-Feb;9(1):37-47. doi: 10.1016/j.ogla.2025.08.009. Epub 2025 Sep 3. Ophthalmol Glaucoma. 2026. PMID: 40912402 Free article. Clinical Trial.
Visual field defects in dementia: A scoping review.
Phu J, Wang H. Phu J, et al. Ophthalmic Physiol Opt. 2025 Sep;45(6):1359-1375. doi: 10.1111/opo.13550. Epub 2025 Jul 26. Ophthalmic Physiol Opt. 2025. PMID: 40716026 Free PMC article.
Comparison of Visual Acuity Outcomes of Enhanced Monofocal Versus Standard Monofocal Intraocular Lenses from a Randomized, Multicenter, Active-Controlled Trial.
Ang RET, Khoramnia R, Uy HS, Hoffmann P, Anello RD, Zalewski D, Januschowski K, de Arriba Palomero P, Böhringer D, Barberá MI, Bertelmann E, Cisiecki S, Dick HB, Lorenz K, Auffarth GU, Ruiz-Mesa R, Relucio AS. Ang RET, et al. J Refract Surg. 2025 Apr;41(4):e300-e309. doi: 10.3928/1081597X-20250218-01. Epub 2025 Apr 1. J Refract Surg. 2025. PMID: 40197064 Free article. Clinical Trial.
Capsular bag performance of an aspheric hydrophobic IOL after conventional phacoemulsification or femtosecond laser-assisted cataract surgery: 12-month results of a randomized prospective study.
Casazza M, Reifeltshammer SA, Hirnschall N, Wendelstein J, Mariacher S, Laubichler P, Siska R, Bolz M. Casazza M, et al. Graefes Arch Clin Exp Ophthalmol. 2025 Oct;263(10):2817-2825. doi: 10.1007/s00417-025-06919-1. Epub 2025 Jul 18. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40679603 Free PMC article. Clinical Trial.
Ophthalmological manifestations, visual outcomes, and treatment of electrical and lightning trauma: A Systematic Review.
Piedrahita MA, Pineda-Vanegas AF, Moreno-Mendoza F, Estévez-Flórez MA, España-Isaza N, Infante-Ortegón V, Rey-Rodríguez DV, Cifuentes-González C, Rodriguez-Camelo LD, Mejía-Salgado G, de-la-Torre A. Piedrahita MA, et al. Graefes Arch Clin Exp Ophthalmol. 2025 Oct;263(10):2955-2973. doi: 10.1007/s00417-025-06844-3. Epub 2025 Jun 27. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40576658 Free PMC article.
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration: A Phase III Randomized Trial.
Hamouz J, Nowosielska A, Święch-Zubilewicz A, Abengoechea S, Baumane K, Vajas A, Siewierska M, Veselovsky M, Veith M, Kerényi Á, Mange S, Baidya K, Laganovska G, Jürgens I, Papp A, Gosai J, Štefanickova J, Han M, Fryczkowski P, Zalewski D, Wang J, Wei W. Hamouz J, et al. Ophthalmol Retina. 2025 Apr;9(4):343-351. doi: 10.1016/j.oret.2024.10.001. Epub 2024 Oct 9. Ophthalmol Retina. 2025. PMID: 39389463 Clinical Trial.
Response of accommodation and vergence systems to low dose atropine.
Woodman-Pieterse EC, Hughes RPJ, Hopkins S, Cunningham AF, Niemand J, Romeo B, Westcott NL. Woodman-Pieterse EC, et al. Ophthalmic Physiol Opt. 2025 Nov;45(7):1608-1621. doi: 10.1111/opo.70013. Epub 2025 Sep 5. Ophthalmic Physiol Opt. 2025. PMID: 40913324 Free PMC article. Clinical Trial.
295 results